Heather Lynn Davis

This inventor holds 16 USPTO granted patents and 2 published patent applications, plus 8 CIPO patents and 5 EPO patents, primarily in Immunology and Vaccines. Top assignees: Coley Pharmaceutical Group, Inc., University of Iowa Research Foundation, Coley Pharmaceutical Gmbh. Active years: 1998-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heather Lynn Davis. Retrieved from https://idiyas.com/inventor/heather-lynn-davis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 2)

% Patents Active = 62.5

CIPO Patents = 8

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 2.5

ph-index = 8

Forward Citations = 1,017(Granted Patents)

Location History:

Dunrobin, CA (2010 - 2015)
Donrobin, CA (2013 - 2016)
Ottawa, CA (1998 - 2019)

Company Filing History:

3 out of 41

Coley Pharmaceutical Group, Inc.

patents

3 out of 926

University of Iowa Research Foundation

patents

2 out of 27

Coley Pharmaceutical Gmbh

Loeb Health Research Institute at the Ottawa Hospital

patent

6. 1 out of 1,853

National Institute of Health and Medical Research

patents

7. 1 out of 1

Ottawa Civic Hospital Loeb Research

patent

8. 1 out of 12

Ottawa Health Research Institute

patents

9. 1 out of 33

Ottawa Hospital Research Institute

13. 4 out of 834,708

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2019

Loading Chart...

Areas of Expertise:

Vaccines

Immunostimulatory Oligonucleotides

Cholesterol Adjuvants

Mucosal Immunity

Nucleotide Vector

CpG Dinucleotide

Nicotine Addiction

Hepatitis C

Antigen-Specific Immune Response

DNA Vaccination

Therapeutic Protocols

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10456463 - Vaccines comprising cholesterol and CpG as sole adjuvant-carrier molecules (2019-10-29),

2. 9453059 - Immunostimulatory oligonucleotides (2016-09-27),

3. 9205143 - Pneumococcal vaccine and uses thereof (2015-12-08),

4. 8980276 - Conjugates for the prevention or treatment of nicotine addiction (2015-03-17),

5. 8574599 - Methods and products for inducing mucosal immunity (2013-11-05),

6. 8552165 - Immunostimulatory oligonucleotides (2013-10-08),

7. 8202688 - Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant (2012-06-19),

8. 7998492 - Methods and products related to treatment and prevention of hepatitis C virus infection (2011-08-16),

9. 7825097 - Nucleotide vector vaccine for immunization against hepatitis (2010-11-02),

10. 7488490 - Method of inducing an antigen-specific immune response by administering a synergistic combination of adjuvants comprising unmethylated CpG-containing nucleic acids and a non-nucleic acid adjuvant (2009-02-10),

11. 6821957 - Vectors and methods for immunization or therapeutic protocols (2004-11-23),

12. 6635624 - Nucleotide vector composition containing such vector and vaccine for immunization against hepatitis (2003-10-21),

13. 6406705 - Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant (2002-06-18),

14. 6339068 - Vectors and methods for immunization or therapeutic protocols (2002-01-15),

15. 6180614 - DNA based vaccination of fish (2001-01-30),

Title: Heather Lynn Davis - Innovative Inventor from Ottawa, CA

Introduction: Heather Lynn Davis is a pioneering inventor based in Ottawa, Canada, known for her groundbreaking contributions to various industries.

Latest Patents: Heather Lynn Davis holds several patents in the fields of renewable energy, sustainable technology, and healthcare innovations, showcasing her diverse range of expertise.

Career Highlights: With a career spanning over two decades, Heather Lynn Davis has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have positively impacted society.

Collaborations: Throughout her career, Heather Lynn Davis has collaborated with leading research institutions, universities, and companies worldwide, fostering a culture of innovation and knowledge exchange.

Conclusion: Heather Lynn Davis continues to inspire the next generation of inventors through her remarkable work and dedication to creating a better future through innovation.

Profile summary based on public USPTO records.